- $470 million: The reported acquisition price of AbleTo Inc. by Optum in 2020.
- 15-fold growth: The expansion of AbleTo under Benton and Stout's leadership.
- Four million tests processed: Ash's current operational scale.
Experts would likely conclude that Ash's strategic hires signal a well-prepared push into the Medicare Advantage market, leveraging proven scaling expertise from AbleTo to drive growth and improve health outcomes.
Ash Recruits 'AbleTo' Veterans for Strategic Medicare Advantage Push
NEW YORK, NY – July 15, 2026 – Ash, a provider of at-home health testing solutions, has made a significant strategic move by appointing two seasoned health tech veterans to its leadership team. Jon Stout, a former health plan executive, joins the company's Board of Directors, while Matt Benton, a finance leader with a track record of steering hypergrowth, steps in as Chief Financial Officer. These appointments are a clear signal of Ash's intent to aggressively scale its operations and deepen its penetration into the complex and lucrative Medicare Advantage market.
The hires bring a wealth of experience from their time at AbleTo Inc., a digital behavioral health company they helped guide through massive growth to an eventual acquisition by UnitedHealth Group's Optum. This shared history provides Ash with what many in the industry see as a proven blueprint for success, combining deep payer-side knowledge with rigorous financial discipline.
“Jon and Matt have both been in the room when a health tech company scales the right way,” said David Stein, CEO and co-founder of Ash. “That kind of experience is exactly what we need as we deepen our work with Payers. Matt brings the financial discipline to scale responsibly, and Jon brings a board-level view shaped by years on both the payer and operator side of growth. We're fortunate to have them.”
The 'AbleTo Effect': A Blueprint for Hypergrowth
The most compelling aspect of these appointments is the shared history of Stout and Benton at AbleTo Inc. Their tenure there was not just a line on a resume; it was a masterclass in scaling a health tech startup into a major industry player. AbleTo was acquired by Optum in 2020 for a reported $470 million, a landmark deal in the digital health space. Benton was a key financial architect during this period, co-leading a $500 million recapitalization with UnitedHealth Group and helping to expand the business roughly 15-fold. Stout, as Chief Growth Officer, was instrumental in driving the market strategy that made such growth possible.
This 'AbleTo Effect' brings more than just experience to Ash; it brings a playbook. The duo has firsthand knowledge of building scalable infrastructure, navigating complex relationships with large payers like UnitedHealth, and managing the financial pressures of hypergrowth. Benton’s subsequent role as CFO at Nayya, where he guided the AI-native benefits platform through 5x growth, further sharpens his expertise in building the financial and operational backbone required for rapid expansion.
For Ash, a company founded in 2019 and already boasting impressive metrics like over four million tests processed, this leadership injection is about preparing for the next stage of its corporate journey. Investors and industry analysts note that such hires are often precursors to significant funding rounds, major strategic partnerships, or an eventual public offering or acquisition. Benton's explicit goal to “build scalable financial infrastructure” and “bridge the gap between growth goals and financial reality” underscores this focus on disciplined, sustainable scaling.
Cracking the Code of Medicare Advantage
Ash's strategic focus is squarely on the Medicare Advantage (MA) market, a sector where health plans are under immense pressure to improve quality metrics while managing costs. Success in this space is heavily dictated by HEDIS (Healthcare Effectiveness Data and Information Set) scores and CMS Star Ratings. A seemingly small half-star increase in ratings can translate into an additional $500 per member in annual revenue for a plan, amounting to millions in quality bonus payments. However, with average star ratings remaining flat in recent years, plans are desperately seeking innovative solutions.
This is where Ash's new leadership is poised to make its greatest impact. Jon Stout's decade at Horizon Blue Cross Blue Shield of New Jersey, where he led value-based programs, gives him an invaluable insider’s perspective. He understands the operational pain points and strategic priorities of payers.
“I've spent my career watching health plans and health tech companies work around each other,” said Jon Stout. “Ash is built to close that gap — literally. I'm looking forward to helping the team think through what disciplined, payer-aligned growth looks like as they scale.”
His role will involve pressure-testing Ash’s growth decisions and refining its core product—at-home testing kits designed to close critical care gaps in areas like Colorectal Cancer Screening and chronic disease management. These are precisely the measures that frequently challenge MA plans and impact their Star Ratings. By providing a white-label solution that allows plans to reach their most disengaged members directly in their homes, Ash addresses key barriers to care like transportation and mobility.
Combined with Benton’s financial acumen, the strategy becomes even more potent. “Health plans are under real pressure to close care gaps at scale, and that's the exact problem Ash was built to solve,” stated Matt Benton. His role will be to ensure that as Ash grows, it can clearly demonstrate a compelling return on investment for its health plan partners, translating closed care gaps into quantifiable improvements in Star Ratings and financial performance.
Scaling Impact: From Boardroom to Member Homes
While the strategic appointments and financial implications are significant, the ultimate goal of Ash's expansion is to improve health outcomes for individuals. The company’s model is specifically designed to activate hard-to-reach populations, using a combination of a seamless, plan-branded member experience and AI-powered engagement to encourage participation. By bringing lab-quality testing into a member's home, Ash removes friction from the healthcare journey, making preventive care more accessible.
The leadership of Stout and Benton is expected to amplify this impact exponentially. Their expertise in scaling operations means Ash can expand its partnerships with hundreds of healthcare organizations nationwide, ensuring its services can be delivered reliably to a growing number of people. This involves sophisticated logistics, a robust network of CLIA-certified and CAP-accredited labs, and HIPAA-compliant technology infrastructure—all areas where proven scaling experience is critical.
As Ash deepens its work with Medicare Advantage plans, the new leadership's ability to navigate the complex payer ecosystem will be crucial. By aligning the company's product roadmap and financial strategy directly with the needs of health plans, Stout and Benton are positioning Ash not just as a vendor, but as an essential partner in the shift towards more proactive, equitable, and value-based healthcare delivery.
Topics & Related
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →